Abstract

Deep-brain-stimulation (DBS) surgery requires implanting stimulators at target positions with submillimetric accuracy. Traditional stereotactic frames can provide such accuracy, but a recent innovation called the microTargeting Platform (FHC, Inc.) replaces this large, universal frame with a single-use, miniature, and custom-designed platform. Both single-target and dual-target platforms are available for unilateral and bilateral procedures, respectively. In this paper, their targeting accuracies are evaluated in vitro. Our approach employs "virtual targets," which eliminates the problem of collision of the implant with the target. We implement virtual targets by mounting fiducial markers, which are not used in platform targeting, on an artificial skull and defining targets relative to the skull via that fiducial system. The fiducial system is designed to surround the targets, thereby reducing the overall effect of fiducial localization inaccuracies on the evaluation. It also provides the geometrical transformation from image to physical space. Target selection is based on an atlas of stimulation targets from a set of 31 DBS patients. The measured targeting error is the displacement between the phantom implant and the virtual target. Our results show that the microTargeting Platform exhibits submillimetric in vitro accuracy with a mean of 0.42 mm and a 99.9% level of 0.90 mm.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.